Telavancin - PDFSEARCH.IO - Document Search Engine

Telavancin
Results: 19

#	Item
1	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use ® VIBATIV (telavancin) safely and effectively. See full prescribing information for VIBATIV. Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2014-12-04 13:27:31 Telavancin Vancomycin Biology Pharmacology Organofluorides Amides Daptomycin Flucytosine Antibiotics Chemistry Eli Lilly and Company
2	Theravance and Astellas to Collaborate on Telavancin, Investigational Antibiotic for Serious Infections SOUTH SAN FRANCISCO, CA and TOKYO, JAPAN/ November 7, [removed]Theravance, Inc., and Astellas Pharma Inc. announced t Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 21:56:16 Pharmacology Astellas Pharma Medicine Lipoglycopeptide Methicillin-resistant Staphylococcus aureus Pharmaceutical industry Vancomycin Antibiotics Telavancin Pharmaceutical sciences
3	Theravance and Astellas Announce FDA Approval of VIBATIV™ (telavancin) for the Treatment of Complicated Skin and Skin Structure Infections SOUTH SAN FRANCISCO, CA and DEERFIELD, IL – September 11, 2009 – Theravance Add to Reading List Source URL: www.astellas.com Language: English - Date: 2009-09-13 21:20:55 Antibiotics Bacterial diseases Staphylococcaceae Eli Lilly and Company Glycopeptide antibiotics Telavancin Vancomycin Staphylococcus aureus Nosocomial infection Bacteria Microbiology Medicine
4	Theravance Receives FDA Approvable Letter for Telavancin for the Treatment of Complicated Skin and Skin Structure Infections SOUTH SAN FRANCISCO, CA and DEERFIELD, IL/OCTOBER 22, 2007 – Theravance, Inc. (NASDAQ: THRX) Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 20:34:44 Pharmaceutical sciences Health Astellas Pharma Methicillin-resistant Staphylococcus aureus Skin and skin structure infection Food and Drug Administration Antibiotics Telavancin Medicine
5	Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Nosocomial Pneumonia and Complicated Skin and Soft Tissue Infections in Europe TOKYO, JAPAN AND SOUTH SAN FRANCISCO, CA/October 28, 2009 Add to Reading List Source URL: www.astellas.com Language: English - Date: 2009-10-28 20:07:57 Bacterial diseases Antibiotics Staphylococcaceae Pathogenic bacteria Telavancin Glycopeptide antibiotics Lipoglycopeptide Methicillin-resistant Staphylococcus aureus Astellas Pharma Bacteria Microbiology Medicine
6	Theravance and Astellas Add Japan to Collaboration on Telavancin, Investigational Antibiotic for Serious Infections SOUTH SAN FRANCISCO, CA and TOKYO, JAPAN/July 18, [removed]Theravance, Inc. (NASDAQ: THRX), and Astellas Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-19 00:50:37 Astellas Pharma Lipoglycopeptide Methicillin-resistant Staphylococcus aureus Pharmaceutical industry Pharmacology Medicine Antibiotics Telavancin Pharmaceutical sciences
7	Astellas and Theravance Announce Submission of Telavancin MAA for the Treatment of Complicated Skin and Soft Tissue Infections in Europe TOKYO, JAPAN AND SOUTH SAN FRANCISCO, CA/May 1, 2007 – Astellas Pharma Inc. (Aste Add to Reading List Source URL: www.astellas.com Language: English - Date: 2008-09-18 21:25:49 Astellas Pharma Pharmaceutical industry Methicillin-resistant Staphylococcus aureus Pharmacology Medicine Antibiotics Telavancin Pharmaceutical sciences
8	Astellas Receives European Marketing Authorisation for VIBATIV® for Nosocomial Pneumonia Caused by MRSA1 Staines, United Kingdom, September 15, 2011 – Astellas Pharma Europe Ltd., a subsidiary of Tokyo based Astellas Add to Reading List Source URL: www.astellas.com Language: English - Date: 2011-09-14 22:51:12 Bacterial diseases Staphylococcaceae Infectious diseases Glycopeptide antibiotics Antibiotics Telavancin Astellas Pharma Methicillin-resistant Staphylococcus aureus Vancomycin Microbiology Bacteria Medicine
9	Changes to EUCAST telavancin breakpoints for S. aureus following changes to MIC methodology In Europe, telavancin is indicated for the treatment of adults with hospital-acquired pneumonia, including ventilator associ Add to Reading List Source URL: www.eucast.org Language: English - Date: 2014-07-07 07:41:07 Bacterial diseases Antibiotics Antibiotic-resistant bacteria Methicillin-resistant Staphylococcus aureus Telavancin Staphylococcus aureus Breakpoint Meticillin Bacteria Microbiology Staphylococcaceae
10	The committee will discuss new drug application (NDA[removed], telavancin sterile powder for injection, application submitted by Theravance, Incorporated, and the requested indication of nosocomial pneumonia, including ven Add to Reading List Source URL: www.fda.gov Language: English Antibiotics Telavancin Pharmacology Center for Drug Evaluation and Research Food and Drug Administration Pharmaceutical sciences Clinical research

UPDATE